The largest database of trusted experimental protocols

Recombinant firefly luciferase

Manufactured by Merck Group
Sourced in United States

Recombinant firefly luciferase is a bioluminescent enzyme derived from the firefly. It catalyzes the oxidation of luciferin, a substrate, to produce light. The enzyme is commonly used in research applications to detect and quantify gene expression and protein activity.

Automatically generated - may contain errors

5 protocols using recombinant firefly luciferase

1

Luminescence-Based Luciferase Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Confirmed qHTS active compounds were tested in a biochemical assay to directly measure potential for luciferase inhibition using Kinase-Glo (Promega). Briefly, 3 μl of substrate buffer (50 mM Tris–HCl [pH 7.5], 10 mM MgCl2, 0.05% bovine serum albumin, 0.01% Tween-20, 13.33 μM d-luciferin (Sigma; catalog no.: L9504), and 13.33 μM ATP) were dispensed into 1536-well assay plates. Compounds were then transferred via Kalypsys pin tool equipped with 1536-pin array. Following addition of compound, 1 μl of recombinant firefly luciferase (Sigma; L9506 prepared in 50 mM Tris–HCl [pH 7.5], 10 mM MgCl2, 0.05% bovine serum albumin, and 0.01% Tween-20; 10 nM final) was added to initiate the reaction. After 10 min of room temperature incubation, end-point measurements of luminescence were acquired using a ViewLux plate reader equipped with clear filters.
+ Open protocol
+ Expand
2

Heat-Induced Luciferase Aggregation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heat induced aggregation of 300 nm recombinant firefly luciferase (Sigma‐Aldrich, St Louis, MO, USA) in buffer G (50 mm HEPES/KOH, pH 7.5, 100 mm KCl, 10 mm MgCl2, 1 mm EDTA, 1 mm DTT and 10% (v/v) glycerol) was monitored by UV absorbance at 320 nm for 25 min at 43 °C in a Varian Cary Eclipse fluorescence spectrophotometer (Santa Clara, CA, USA) equipped with a temperature controller. Various concentrations of ClpB or ClpB∆N protein were added to the reaction, with 5 mm of ATP or other indicated nucleotides, prior to heat aggregation and their effect on the aggregation of luciferase was recorded. The end‐point value of the absorbance of aggregated luciferase alone was considered as 100% aggregation. The percentage aggregation of other variables was calculated relative to this value.
+ Open protocol
+ Expand
3

Luminescence-Based Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant firefly luciferase (Sigma-Aldrich, St. Louis, Missouri, United States) was diluted to 104 U/mg in 1× PBS (phosphate buffered saline) and subsequently incubated with NFA or the substances of interest for 15 min at 37°C. Afterwards, 50 µl per reaction mix was transferred into a white 96-well plate, to which 50 µl/well Dual-Glo® (Promega, Madison, Wisconsin, United States) was added and incubated for another 10 min at 37°C. Luminescence was analyzed with a plate reader.
+ Open protocol
+ Expand
4

Matrigel-Based Luminescent Enzyme Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Matrigel® was purchased from Corning, USA (cat. # 356237); ATP disodium salt was purchased from AppliChem GmbH, Germany (cat. # A1348-0005); MgSO4 ·7H2O – AlfaAesar, Germany (cat. # A14491-0B); PBS – ThermoFisher Scientific, USA (cat.# 10010-015); recombinant firefly luciferase – Sigma-Aldrich (cat.# SRE0045); D-luciferin – Perkin Elmer, USA (cat.# 122799); DEX – Sigma-Aldrich (cat.# 31375); QIAGEN RNeasy kit - QIAGEN, Switzerland; Q-Gel - QGel SA, Switzerland; and collagen, DEX, sitagliptin – Sigma-Aldrich. DPP-4-specific caged luciferin probe (DAL) and Luciferin-IPATM were chemically synthesized according to the published protocols12 ,45 (link).
+ Open protocol
+ Expand
5

Quantifying Total ATP Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total ATP concentration was measured using the luciferase bioassay. The bioluminescence assay is based on the reaction of ATP with recombinant firefly luciferase (Sigma-Aldrich, Saint Louis, MO, USA) and its substrate luciferin (Sigma).
Cells or tissue were lysed in 20 μl of 1.35 M perchloric acid and then neutralized with 15 μl of 2.8 M KHCO3-0.1 M Tris. Ten microliters of the supernatant were used for the luciferase reaction by adding 10 μl of luciferase and 100 μl luciferin. Luminescence was determined in a luminometer (BG-P luminometer; GEM Biomedical, Hamden, CT). The results were normalized by total protein and expressed them all as a percentage.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!